A Randomized Trial to Evaluate the Sustained Efficacy of a Mucus Clearance Device in Ambulatory Patients with Chronic Obstructive Pulmonary Disease
OBJECTIVE: To determine whether a mucus clearance device (MCD) (Flutter; Axcan Scandipharm, USA) could consistently improve the bronchodilator response and exercise performance in patients with chronic obstructive pulmonary disease (COPD) when used in an ambulatory setting over a one-week period.
Saved in:
Main Authors: | Norman Wolkove, Marc A Baltzan, Hany Kamel, Michael Rotaple |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2004/828591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Compliance with Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea
by: Norman Wolkove, et al.
Published: (2008-01-01) -
Amiodarone Pulmonary Toxicity
by: Norman Wolkove, et al.
Published: (2009-01-01) -
Effects of Sodium Fluoride on Water and Acid Secretion, Soluble Mucus and Adherent Mucus of the Rat Stomach
by: Kamel Gharzouli, et al.
Published: (2000-01-01) -
Ambulatory Monitoring for Obstructive Sleep Apnea: It’s Not the Device That Matters, but How the Data Are Used
by: Frank Ryan
Published: (2011-01-01) -
Meal Induced Oxygen Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease
by: Norman Wolkove, et al.
Published: (1998-01-01)